Quantcast
Last updated on April 23, 2014 at 10:30 EDT

Latest Virology Stories

2013-01-11 10:16:27

The detailed changes in the structure of a virus as it infects an E. coli bacterium have been observed for the first time, report researchers from The University of Texas at Austin and The University of Texas Health Science Center at Houston (UT Health) Medical School this week in Science Express. To infect a cell, a virus must be able to first find a suitable cell and then eject its genetic material into its host. This robot-like process has been observed in a virus called T7 and...

2013-01-10 12:24:02

Genomes are Deposited into GenBank and Available as Worldwide Research Resource to Better Understand and Combat Potential Influenza Epidemics and Pandemics ROCKVILLE, Md., Jan. 10, 2013 /PRNewswire-USNewswire/ -- Scientists at the J. Craig Venter Institute (JCVI), along with researchers at the National Center for Biotechnology Information (NCBI) and 44 academic institutions have sequenced and published more than 10,000 influenza virus genomes as part of the Influenza Virus Genome...

2013-01-09 04:21:25

BLUE BELL, Pa., Jan. 9, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) and its development partner VGX International, Inc. (KSE: 011000) will move Inovio's hepatitis C (HCV) DNA vaccine into a phase I/IIa clinical trial by the end of 2013. This advancement is based on outstanding results of a preclinical study which demonstrated for the first time that a multi-antigen SynCon® HCV vaccine can generate robust T-cell responses not only in the blood but, more importantly,...

2013-01-08 08:30:31

SAN DIEGO, Jan. 8, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), announced that Chief Executive Officer Jim Joyce will give a corporate presentation today at Biotech Showcase 2013. The presentation is scheduled to start at 4:45 p.m. Pacific Standard Time and can be accessed online at http://www.media-server.com/m/p/54bc8kj7. The conference is being held in San Francisco at the Parc 55 Wyndham Union Square Hotel. (Photo:...

2013-01-04 12:23:11

ZURICH-SCHLIEREN, Switzerland, Jan. 4, 2013 /PRNewswire/ -- GlycoVaxyn AG, a leader in the development of innovative vaccines, today announced that Janssen Pharmaceuticals, Inc. (JPI), has signed an exclusive license agreement and entered into a three-year research and development collaboration to develop a multi-valent bacterial vaccine employing GlycoVaxyn's bio-conjugation technology. "Bacterial pathogens that exist in multiple pathogenic strains pose significant challenges for developing...

2013-01-03 08:25:52

SAN DIEGO, Jan. 3, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, disclosed today that it has submitted an Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) that requests permission to initiate a clinical feasibility study of Hepatitis-C (HCV) infected individuals enrolled to receive Hemopurifier®...

2012-12-21 05:01:55

Five well known experts gathered in London to discuss research supporting Echinaforce® for prevention and treatment of cold and flu; their comments on the current research now available on You Tube. Roggwil, Switzerland (PRWEB) December 20, 2012 Echinacea is a popular herb used to treat colds and flu in many parts of the world, yet reports on its efficacy have been mixed. With the recent discovery of anti-viral, anti-inflammatory and immune modulating activity, there has been renewed...

2012-12-19 08:24:49

ZURICH-SCHLIEREN, Switzerland, Dec. 19, 2012 /PRNewswire/ -- GlycoVaxyn AG, a leader in the development of innovative vaccines, today announced a collaboration with GlaxoSmithKline Biologicals (GSK) to develop new bacterial vaccines employing GlycoVaxyn's bio-conjugation technology. "GlycoVaxyn's technology is designed to enable or improve the development of anti-bacterial conjugate vaccines by in vivo synthesis of protein-polysaccharide complexes in E. coli, via recombinant DNA technology,"...

2012-12-17 08:24:47

GAITHERSBURG, Md., Dec. 17, 2012 /PRNewswire/ -- GenVec, Inc. (NASDAQ:GNVC) announced today that data were presented on its HSV vaccine program at the Keystone Symposia meeting on Immunological Mechanisms of Vaccination, which is taking place in Ottawa, Ontario from December 13 to December 18, 2012. The company disclosed that a single administration of its genetic vaccine was effective against HSV2 in two industry-accepted HSV disease models. Specifically, immunization was shown to...

2012-11-29 08:30:19

NES ZIONA, Israel, November 29, 2012 /PRNewswire/ -- NanoPass Technologies Ltd. ("NanoPass"), a pioneer in intradermal delivery solutions for vaccines, announced today that it has entered into a license agreement for MicronJet(R), its microneedle delivery device, with Janssen Pharmaceuticals, Inc. (JPI) for multiple vaccine fields. The license agreement will provide Janssen with an exclusive license to use the device in its seasonal influenza programs and options for...


Latest Virology Reference Libraries

Virology Journal
2012-04-24 18:40:35

Virology Journal is an open-access peer-reviewed medical journal published by BioMed Central. It covers research related to viruses and the prevention of viral infection (including vaccination, the use of antiviral agents, and gene therapy). Virology Journal was established in 2004 and is edited by Robert F. Garry. The goal of the journal is to cover rapid communications amongst virologists. The journal has not been published without controversy, however. On 21, July 2010, the journal...

2012-04-24 18:35:41

Virology is a peer-reviewed academic journal covering basic research into viruses affecting animals, plants, bacteria and fungi. It includes the molecular biology, structure, assembly, pathogenesis, immunity and interactions viruses have with the host cell. The journal also covers aspects of control and prevention, as well as viral vectors and gene therapy. Virology was established in 1955 and is now published bi-weekly by the Academic Press imprint of Elsevier. Subscribers of Virology...

0_c4753f392575c29d1886d90b7b382782
2011-02-23 21:28:34

A virus is a small infectious agent that replicates inside the living cells of organisms. It is a small infectious agent that can replicate only inside the living cells of organisms. Most are too small to be seen by anything but a microscope and they infect all organisms from animals to plants to bacteria. The first one discovered was the tobacco virus in 1898. Since then around 5,000 viruses have been described in detail although there are millions of different types. They are found in...

70_1a57dceb4fac796cf2ab07fe90a19d10
2011-02-23 21:23:46

Vesicular stomatitis virus (VSV) is a virus in the family Rhabdoviridae. Rabies is in the same family. VSV infects insects and animals and is important to farmers in certain regions of the world where it can infect cattle. It is a common laboratory virus used for studying the Rhabdoviridae family and viral evolution. It is the prototypic member of the vesiculovirus genera of the Rhabdovirus family. The genome is a single molecule of negative-sense RNA that encodes five major proteins.

70_3535864920345861b4838317cda6792c
2011-02-23 21:08:22

Tobacco mosaic virus (TMV) is a positive-sense single stranded RNA virus that infects plants, namely tobacco and other members of the family Solanaceae. It causes characteristic patterns on the leaves. In 1930 it was determined that an infectious agent was determined to be a virus. Adolf Mayer first described the disease in 1883. The disease can be transferred between plants similar to bacterial infections. Dimitri Ivanovski was the first to show that infected sap remained infectious even...

More Articles (18 articles) »